Literature DB >> 16359738

Sequence polymorphisms in the receptor-binding domain of Plasmodium falciparum EBA-175: implications for malaria vaccine development.

Anitha Mamillapalli1, Priyabrata Pattnaik, Monal Sharma, Surya K Sharma, Prajesh K Tyagi, Hema Joshi, Chetan E Chitnis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16359738     DOI： 10.1016/j.molbiopara.2005.09.019

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  8 in total

1.  Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine.

Authors:  Lubin Jiang; Deepak Gaur; Jianbing Mu; Hong Zhou; Carole A Long; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

2.  Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.

Authors:  Kristina E M Persson; Freya J I Fowkes; Fiona J McCallum; Nimmo Gicheru; Linda Reiling; Jack S Richards; Danny W Wilson; Sash Lopaticki; Alan F Cowman; Kevin Marsh; James G Beeson
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

3.  Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.

Authors:  Kristina E M Persson; Fiona J McCallum; Linda Reiling; Nicole A Lister; Janine Stubbs; Alan F Cowman; Kevin Marsh; James G Beeson
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

4.  Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.

Authors:  Alok K Pandey; K Sony Reddy; Tajali Sahar; Sonal Gupta; Hina Singh; E Jyotheeswara Reddy; Mohd Asad; Faiza A Siddiqui; Pankaj Gupta; Bijender Singh; Kunal R More; Asif Mohmmed; Chetan E Chitnis; Virander S Chauhan; Deepak Gaur
Journal:  Infect Immun       Date:  2012-11-26       Impact factor: 3.441

5.  Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development.

Authors:  Francis B Ntumngia; Amy M McHenry; John W Barnwell; Jennifer Cole-Tobian; Christopher L King; John H Adams
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

6.  The RNA structurome in the asexual blood stages of malaria pathogen plasmodium falciparum.

Authors:  Diana Renteria Alvarez; Alejandra Ospina; Tiffany Barwell; Bo Zheng; Abhishek Dey; Chong Li; Shrabani Basu; Xinghua Shi; Sabah Kadri; Kausik Chakrabarti
Journal:  RNA Biol       Date:  2021-06-23       Impact factor: 4.766

7.  Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.

Authors:  Ulrich Terheggen; Damien R Drew; Anthony N Hodder; Nadia J Cross; Cleopatra K Mugyenyi; Alyssa E Barry; Robin F Anders; Sheetij Dutta; Faith H A Osier; Salenna R Elliott; Nicolas Senn; Danielle I Stanisic; Kevin Marsh; Peter M Siba; Ivo Mueller; Jack S Richards; James G Beeson
Journal:  BMC Med       Date:  2014-10-16       Impact factor: 8.775

8.  Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.

Authors:  Anitha Mamillapalli; Sujatha Sunil; Suraksha S Diwan; Surya K Sharma; Prajesh K Tyagi; Tridibes Adak; Hema Joshi; Pawan Malhotra
Journal:  Malar J       Date:  2007-07-20       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.